Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.

Joakim AlfredssonJennifer B GreenSusanna R StevensShelby D ReedPaul W ArmstrongM Angelyn BethelSamuel S EngelDarren K McGuireFrans Van de WerfIrene HramiakHarvey D WhiteEric D PetersonRury R Holmannull null

Published in: Diabetes, obesity & metabolism (2018)

In this large prospective study of people with type 2 diabetes and CV disease, women had different CV disease burden, worse CV risk factor profiles, and less use of indicated medications than men. Despite this, women had significantly lower risk of CV events, suggesting that the cardioprotective effects of female sex extend to populations with type 2 diabetes.

Keyphrases

cardiovascular disease
polycystic ovary syndrome
risk factors
pregnancy outcomes
cervical cancer screening
adipose tissue
coronary artery disease
cardiovascular events